News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
580,763 Results
Type
Article (19125)
Company Profile (166)
Press Release (561394)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (198753)
Career Advice (710)
Deals (30767)
Drug Delivery (86)
Drug Development (65668)
Employer Resources (56)
FDA (12431)
Job Trends (11151)
News (288359)
Policy (24205)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (843)
Accelerated approval (39)
ADA (26)
Adcomms (10)
Allergies (139)
Alliances (41902)
ALS (140)
Alzheimer's disease (1261)
Antibody-drug conjugate (ADC) (336)
Approvals (13023)
Artificial intelligence (494)
ASCO (219)
Autoimmune disease (240)
Automation (41)
Bankruptcy (319)
Best Places to Work (8416)
BIO (47)
BIOSECURE Act (10)
Biosimilars (183)
Biotechnology (103)
Bladder cancer (149)
Brain cancer (55)
Breast cancer (592)
Cancer (4389)
Cardiovascular disease (343)
Career advice (615)
Career pathing (16)
CAR-T (214)
CDC (8)
Celiac Disease (1)
Cell therapy (602)
Cervical cancer (41)
Clinical research (58741)
Collaboration (1672)
Commercialization (1)
Company closure (1)
Compensation (1415)
Complete response letters (60)
COVID-19 (1282)
CRISPR (82)
C-suite (1008)
Cystic fibrosis (123)
Data (6481)
Decentralized trials (1)
Denatured (23)
Depression (123)
Dermatology (66)
Diabetes (433)
Diagnostics (4798)
Digital health (43)
Diversity (3)
Diversity, equity & inclusion (17)
Drug discovery (255)
Drug pricing (126)
Drug shortages (15)
Duchenne muscular dystrophy (223)
Earnings (80735)
Editorial (25)
Employer branding (5)
Employer resources (53)
Events (99282)
Executive appointments (937)
FDA (15481)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (27)
Funding (1194)
Gene editing (162)
Generative AI (35)
Gene therapy (452)
GLP-1 (669)
Government (2013)
Grass and pollen (5)
Guidances (330)
Healthcare (11123)
Hematology (129)
HIV (56)
Huntington's disease (28)
IgA nephropathy (94)
Immunology and inflammation (165)
Immuno-oncology (74)
Indications (189)
Infectious disease (1513)
Inflammatory bowel disease (172)
Inflation Reduction Act (9)
Influenza (96)
Intellectual property (287)
Interviews (94)
IPO (13981)
IRA (33)
Job creations (3110)
Job search strategy (555)
JPM (29)
Kidney cancer (18)
Labor market (39)
Layoffs (250)
Leadership (13)
Legal (6595)
Liver cancer (54)
Longevity (21)
Lung cancer (613)
Lymphoma (334)
Machine learning (35)
Management (19)
Manufacturing (877)
Marketing (8)
MASH (162)
Medical affairs (1)
Medical device (9276)
Medtech (9404)
Mergers & acquisitions (17921)
Metabolic disorders (1044)
mRNA (105)
Multiple sclerosis (138)
NASH (15)
Neurodegenerative disease (289)
Neuropsychiatric disorders (68)
Neuroscience (2383)
Neurotech (1)
NextGen: Class of 2026 (3947)
Non-profit (1278)
Now hiring (23)
Obesity (418)
Opinion (160)
Ovarian cancer (173)
Pain (239)
Pancreatic cancer (219)
Parkinson's disease (270)
Partnered (20)
Patents (561)
Patient recruitment (564)
Peanut (39)
People (50672)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase 1 (18123)
Phase 2 (25828)
Phase 3 (19155)
Pipeline (7997)
Policy (165)
Postmarket research (2128)
Preclinical (7528)
Press Release (51)
Prostate cancer (230)
Psychedelics (29)
Radiopharmaceuticals (266)
Rare diseases (827)
Real estate (4477)
Recruiting (21)
Regulatory (19628)
Reports (22)
Research institute (962)
Resumes & cover letters (95)
Rett syndrome (40)
RNA editing (12)
RSV (52)
Schizophrenia (144)
Series A (218)
Series B (153)
Service/supplier (4)
Sickle cell disease (97)
Special edition (11)
Spinal muscular atrophy (112)
Sponsored (16)
Startups (2789)
State (2)
Stomach cancer (8)
Supply chain (92)
Tariffs (71)
The Weekly (53)
Vaccines (503)
Venture capital (54)
Weight loss (223)
Women's health (95)
Worklife (4)
Date
Today (57)
Last 7 days (306)
Last 30 days (1464)
Last 365 days (23205)
2026 (13071)
2025 (23332)
2024 (27291)
2023 (31411)
2022 (40812)
2021 (43408)
2020 (39954)
2019 (29910)
2018 (22794)
2017 (24725)
2016 (23613)
2015 (29497)
2014 (25717)
2013 (22114)
2012 (24133)
2011 (24468)
2010 (23691)
Location
Africa (469)
Alabama (76)
Alaska (2)
Arizona (318)
Arkansas (13)
Asia (30164)
Australia (4158)
California (12182)
Canada (3351)
China (996)
Colorado (491)
Connecticut (445)
Delaware (266)
Europe (54628)
Florida (1849)
Georgia (391)
Hawaii (2)
Idaho (49)
Illinois (831)
India (86)
Indiana (540)
Iowa (14)
Japan (541)
Kansas (115)
Kentucky (37)
Louisiana (29)
Maine (27)
Maryland (1312)
Massachusetts (8399)
Michigan (316)
Minnesota (578)
Mississippi (5)
Missouri (104)
Montana (27)
Nebraska (17)
Nevada (114)
New Hampshire (68)
New Jersey (3084)
New Mexico (18)
New York (3014)
North Carolina (1465)
North Dakota (4)
Northern California (6061)
Ohio (289)
Oklahoma (17)
Oregon (27)
Pennsylvania (2335)
Puerto Rico (26)
Rhode Island (35)
South America (734)
South Carolina (78)
South Dakota (1)
Southern California (5019)
Tennessee (141)
Texas (1942)
United States (41340)
Utah (368)
Vermont (1)
Virginia (254)
Washington D.C. (51)
Washington State (952)
West Virginia (2)
Wisconsin (98)
Wyoming (1)
580,763 Results for "elite pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Claritas Rx Chief Technology Officer Bhupesh Bajaj Named to PM360 ELITE 100 List
May 14, 2026
·
1 min read
Press Releases
Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
June 2, 2026
·
4 min read
Press Releases
Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets
April 2, 2026
·
7 min read
Press Releases
Leica Biosystems Solidifies Leadership in Digital Pathology with Launch of Next-Generation Aperio GT Elite Scanner and Aperio iQC Software
March 23, 2026
·
4 min read
Policy
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Elite Pharmaceuticals, Inc. announced that it received approval from the US Food and Drug Administration for an Abbreviated New Drug Application for generic Methotrexate Sodium 2.5 mg tablets.
May 20, 2024
·
2 min read
Press Releases
Advancing Diagnostic Care: Saskatchewan’s First Modular MRI Cassette™ to House One of Canada’s First MAGNETOM Flow.Elite MRI Systems
March 11, 2026
·
5 min read
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
Business
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
Elite Pharmaceuticals, Inc. announced results for the third quarter of fiscal year 2024 ended December 31, 2023.
February 14, 2024
·
3 min read
Business
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing and manufacturing niche generic products, announced the appointment of Carter Ward as its Chief Financial Officer, effective September 5, 2023.
September 7, 2023
·
3 min read
Pharm Country
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
Elite Pharmaceuticals, Inc. announced today that the third quarter financial results of the 2024 fiscal year will be released on Wednesday, February 14, 2024.
February 8, 2024
·
2 min read
1 of 58,077
Next
